Abstract
Introduction: Biallelic variants in the SCL35D1 gene have been originally associated with a severe skeletal dysplasia called “Schneckenbecken dysplasia” because of the resemblance of the pelvic shape to a snail. More recently, SLC35D1 variants have been associated with much milder phenotypes of skeletal dysplasia. Our report describes one such individual with a novel SLC35D1 variant. Case Presentation: A 17-year-old male with a coarse face and short stature was referred to our clinic. On his radiographic imaging, shortness of the long bones and metaphyseal flaring were detected. Using a clinical exome panel, we discovered a novel homozygous missense variant in the SLC35D1 gene, c.899G>T (p.Gly300Val). Conclusions: We identified a biallelic variant that was causative for a mild skeletal dysplasia and showed its phenotypic effects. Our observation confirms the existence of nonlethal skeletal dysplasias associated with biallelic SLC35D1 variants and suggests the existence of a phenotypic spectrum.
Journal Section:
Novel Insights from Clinical Practice
References
1.
Borochowitz
Z
, Jones
K
, Silbey
R
, Adomian
G
, Lachman
R
, Rimoin
D
et al. A distinct lethal neonatal chondrodysplasia with snail-like pelvis: Schneckenbecken dysplasia
. Am J Med Genet
. 1986
;25
(1
):47
–59
.2.
Camera
G
, Scarano
G
, Tronci
A
, La Cava
G
, Mastroiacovo
P
. “Snail-like pelvis” chondrodysplasia: a further case report
. Am J Med Genet
. 1991
;40
(4
):513
–4
.3.
Furuichi
T
, Kayserili
H
, Hiraoka
S
, Nishimura
G
, Ohashi
H
, Alanay
Y
et al. Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases
. J Med Genet
. 2009
;46
(8
):562
–8
.4.
Giedion
A
, Biedermann
K
, Briner
J
, Soler
R
, Spycher
M
. Case report 693: Schneckenbecken dysplasia
. Skeletal Radiol
. 1991
;20
(7
):534
–8
.5.
Hiraoka
S
, Furuichi
T
, Nishimura
G
, Shibata
S
, Yanagishita
M
, Rimoin
DL
et al. Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human
. Nat Med
. 2007
;13
(11
):1363
–7
.6.
Ishida
N
, Kawakita
M
. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35)
. Pflugers Arch
. 2004
;447
(5
):768
–75
.7.
Muraoka
M
, Kawakita
M
, Ishida
N
. Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity
. FEBS Lett
. 2001
495
1-2
87
93
.8.
Nikkels
P
, Stigter
RH
, Knol
IE
, van der Harten
HJ
. Schneckenbecken dysplasia, radiology, and histology
. Pediatr Radiol
. 2001
;31
(1
):27
–30
.9.
Özer
L
, Aktuna
S
, Unsal
E
, Ünal
MA
, Sahin
G
, Baltaci
V
. A novel SLC35D1 variant causing milder phenotype of Schneckenbecken dysplasia in a large pedigree
. Am J Med Genet
. 2022
;188
(10
):3078
–83
.10.
Rautengarten
C
, Quarrell
OW
, Stals
K
, Caswell
RC
, De Franco
E
, Baple
E
et al. A hypomorphic allele of SLC35D1 results in Schneckenbecken-like dysplasia
. Hum Mol Genet
. 2019
;28
(21
):3543
–51
.11.
Richards
S
, Aziz
N
, Bale
S
, Bick
D
, Das
S
, Gastier-Foster
J
et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology
. Genet Med
. 2015
;17
(5
):405
–24
.12.
Unger
S
, Ferreira
CR
, Mortier
GR
, Ali
H
, Bertola
DR
, Calder
A
et al. Nosology of genetic skeletal disorders: 2023 revision
. Am J Med Genet
. 2023
;191
(5
):1164
–209
.13.
Varkey
J
, Jones
R
. Perinatally lethal, short-limbed dwarfism with distinct features—Schneckenbecken dysplasia
. Ultrasound Obstet Gynecol
. 2004
;24
(5
):575
–7
.14.
Zeb
A
, Shinwari
N
, Shah
K
, Gilani
SZT
, Khan
S
, Lee
KW
et al. Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux
. Int J Biochem Cell Biol
. 2018
;102
:76
–86
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
